2009•Xiandai shengwu yixue jinzhanRequires access

Effects of valsartan, a type 1 angiotensin II receptor antagonist,on airway smooth muscle cells proliferation

Dan Chen

Open publisher page 0 citations

Abstract

Objective: To investigate the effect of type 1 angiotensin II receptor antagonist on airway smooth muscle cells prolifer-ation.Methods: Human airway smooth muscle cells(HASMCs) derived from human bronchus were cultured and stimulated with or with-out valsartan and angiotensin II in vitro.The proliferation rate of HASMCs was detected by MTT method.Cell cycle was detected by flow cytometry.Real-time PCR was explored to measure the mRNA expression level of transforming growth factor-β1(TGF-β1).Re-sults:(1)The proliferation rate of HASMCs was increased significantly in Ang II group.Compared with control group(P0.05),valsartan,a type 1 angiotensin II receptor antagonist,decreased the proliferation rate of cells stimulated by Ang II(P0.05).(2)Flow cytometry dis-closed that the Ang II increased significantly S phase of HASMCs(P0.05);valsartan decreased S phase of cells stimulated by Ang II(P0.05).(3)The expression of TGF-β1mRNA in the Ang II group were higher than that of control group(P0.05) and valsartan + Ang II group(P0.05).Conclusions: Type 1 angiotensin II receptor antagonist can inhibit the proliferation of HASMCs induced by AngII,prob-ably through the down-regulation of TGF-β1.

About this research paper

What this paper is about

Objective: To investigate the effect of type 1 angiotensin II receptor antagonist on airway smooth muscle cells prolifer-ation.Methods: Human airway smooth muscle cells(HASMCs) derived from human bronchus were cultured and stimulated with or with-out valsartan and angiotensin II in vitro.The proliferation rate of HASMCs was detected by MTT method.Cell cycle was detected by flow cytometry.Real-time PCR was explored to measure the mRNA expression level of transforming growth factor-β1(TGF-β1).Re-sults:(1)The proliferation rate of HASMCs was increased significantly in Ang II group.Compared with control group(P0.05),valsartan,a type 1 angiotensin II receptor antagonist,decreased the proliferation rate of cells stimulated by Ang II(P0.05).(2)Flow cytometry dis-closed that the Ang II increased significantly S phase of HASMCs(P0.05);valsartan decreased S phase of cells stimulated by Ang II(P0.05).(3)The expression of TGF-β1mRNA in the Ang II group were higher than that of control group(P0.05) and valsartan + Ang II group(P0.05).Conclusions: Type 1 angiotensin II receptor antagonist can inhibit the proliferation of HASMCs induced by AngII,prob-ably through the down-regulation of TGF-β1.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the effect of type 1 angiotensin II receptor antagonist on airway smooth muscle cells prolifer-ation.Methods: Human airway smooth muscle cells(HASMCs) derived from human bronchus were cultured and stimulated with or with-out valsartan and angiotensin II in vitro.The proliferation rate of HASMCs was detected by MTT method.Cell cycle was detected by flow cytometry.Real-time PCR was explored to measure the mRNA expression level of transforming growth factor-β1(TGF-β1).Re-sults:(1)The proliferation rate of HASMCs was increased significantly in Ang II group.Compared with control group(P0.05),valsartan,a type 1 angiotensin II receptor antagonist,decreased the proliferation rate of cells stimulated by Ang II(P0.05).(2)Flow cytometry dis-closed that the Ang II increased significantly S phase of HASMCs(P0.05);valsartan decreased S phase of cells stimulated by Ang II(P0.05).(3)The expression of TGF-β1mRNA in the Ang II group were higher than that of control group(P0.05) and valsartan + Ang II group(P0.05).Conclusions: Type 1 angiotensin II receptor antagonist can inhibit the proliferation of HASMCs induced by AngII,prob-ably through the down-regulation of TGF-β1.

Key concepts: Valsartan, Angiotensin II, Antagonist, Angiotensin II receptor type 1, Internal medicine, Endocrinology, Vascular smooth muscle, Flow cytometry

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of valsartan, a type 1 angiotensin II receptor antagonist,on airway smooth muscle cells proliferation — Research Paper | ScholarLens